Login

Healthcare

00:00:00
Oventus Medical out to transform the sleep-disordered breathing market with new tech - John Cox , CEO, Oventus Medical Ltd
00:00:00
Oxurion: Developing Innovative Therapies for Diabetic Eye Disease - Patrik De Haes, CEO, Oxurion
00:00:00
Paion advancing its general anesthesia drug candidate - Wolfgang Soehngen, CEO, Paion
00:00:00
Executive Interview - Paion - Wolfgang Soehngen, CEO, Paion
00:00:00
Paradigm Biopharma – executive interview - Paul Rennie, CEO, co-founder and chairman, Paradigm Biopharmaceuticals Ltd
00:00:00
Paragon Care (ASX:PGC) Presentation, FNN Online Investor Event - Phil Nicholl, CEO, Paragon Care Ltd
00:00:00
Patrys CEO & MD, Dr James Campbell
00:00:00
Paxman AB (OM:PAX) Investor Presentation - Richard Paxman,CEO, Paxman AB (publ)
00:00:00
Pharmaxis to accelerate plans for myelofibrosis combination study after FDA talks- Gary Phillips, CEO, Pharmaxis Ltd
00:00:00
Gary Phillips, CEO of Australian biopharma company, Pharmaxis Ltd, discusses ensuring continuity of supply of its products - Gary Phillips, CEO, Pharmaxis Ltd
00:00:00
Realm Therapeutics plc - Equity Development Investor Forum - Alex Martin, CEO, Realm Therapeutics
00:00:00
Proteomics International focused on first commercial sales for PromarkerD in USA - Dr Richard Lipscombe, MD, Proteomics International Laboratories Ltd
00:00:00
Dr. Mariola Söhngen Chief Executive Officer and Executive Director, Proteome Sciences
00:00:00
Phylogica (ASX:PYC) talks strategy and platform direction - Stephanie Unwin, CEO, Phylogica Ltd
00:00:00
Lloyd Diamond Presents Pixium Vision - Lloyd Diamond CEO, Pixium Vision
00:00:00
Pixium Vision | Lloyd Diamond - President & CEO

© 2017 - Townhall + Tv